Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Schleswig-Holstein |
---|---|
Information provided by: | University of Schleswig-Holstein |
ClinicalTrials.gov Identifier: | NCT00638729 |
alpha2-agonists like clonidine offer several useful effects that make these drugs an interesting alternative to benzodiazepines for pharmacological premedication. We therefore sought to determine the effect of pre-anesthetic medication with clonidine vs. midazolam in a randomized, double-blind, placebo controlled study. Effects of pre-anesthetic medication were assessed on (1) bispectral index (BIS),(2) sedation score and visual analog scales for anxiety and pain, (3) neuropsychologic tests to assess cognitive function and (4) circulating stress hormones.
Condition | Intervention |
---|---|
Anxiety Pain |
Drug: midazolam Drug: clonidine Drug: placebo |
Study Type: | Interventional |
Study Design: | Supportive Care, Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Placebo Control, Parallel Assignment |
Official Title: | Effects of Clonidine and Midazolam Premedication on Bispectral Index and Recovery After Elective Surgery |
Enrollment: | 60 |
Study Start Date: | August 2005 |
Study Completion Date: | March 2007 |
Primary Completion Date: | March 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Midazolam: Active Comparator
Pre-anesthetic medication with midazolam, 7.5 mg p.o., 60-90 min prior to estimated induction time
|
Drug: midazolam
midazolam, 7.5 mg p.o., 60-90 min prior to estimated induction time
|
Clonidine: Active Comparator
pre-anesthetic medication with clonidine, 150 µg p.o., 60-90 min prior to estimated induction time
|
Drug: clonidine
pre-anesthetic medication with clonidine, 150 µg p.o., 60-90 min prior to estimated induction time
|
Placebo: Placebo Comparator
Pre-anesthetic medication with an inert tablet, p.o., 60-90 min prior to estimated induction time
|
Drug: placebo
inert tablet p.o., 60-90 min prior to estimated induction time
|
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Germany | |
Department of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel | |
Kiel, Germany, 24105 |
Study Chair: | Jens Scholz, M.D. | Chair of the Dept. of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel |
Responsible Party: | Chair of the Department of Anaesthesiology and Intensive Care Medicine, University Schleswig-Holstein Campus Kiel ( Prof. Dr. J. Scholz ) |
Study ID Numbers: | A 157/01, A 157/01 |
Study First Received: | March 12, 2008 |
Last Updated: | March 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00638729 History of Changes |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
bispectral index sedation stress hormones cognitive function |
Anesthetics, Intravenous Neurotransmitter Agents Tranquilizing Agents Adrenergic alpha-Agonists Adrenergic Agents Clonidine Psychotropic Drugs Adjuvants, Immunologic Central Nervous System Depressants Stress Anesthetics |
Pain Cardiovascular Agents Midazolam Antihypertensive Agents Hormones Adrenergic Agonists Anesthetics, General Hypnotics and Sedatives Anti-Anxiety Agents Analgesics Peripheral Nervous System Agents |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents GABA Modulators Physiological Effects of Drugs Psychotropic Drugs Anesthetics Adrenergic Agonists Sensory System Agents Therapeutic Uses Hypnotics and Sedatives Analgesics Anesthetics, Intravenous Sympatholytics Adrenergic alpha-Agonists |
Tranquilizing Agents Clonidine Central Nervous System Depressants Cardiovascular Agents Midazolam Antihypertensive Agents Pharmacologic Actions Adjuvants, Anesthesia Anesthetics, General Autonomic Agents GABA Agents Anti-Anxiety Agents Peripheral Nervous System Agents Central Nervous System Agents |